Bilastina AlterPharma 20 mg tablets

Spain
Brand name Bilastina AlterPharma 20 mg tablets
Form tablets
Active substance / Dosage
BILASTINE · 20 mg
Prescription type Over The Counter
Registration number 86155
Bilastina AlterPharma 20 mg tablets tablets

Package leaflet: Information for the user

Introduction

Package leaflet: information for the patient

Bilastina Alterpharma 20 mg tablets

bilastine

Read the entire leaflet carefully before you start taking this medicine, because it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any questions, consult your doctor or pharmacist.
  • This medicine has been prescribed for you only, and you should not give it to others, even if they have the same symptoms as you, because it may harm them.
  • If you experience any adverse reactions, consult your doctor or pharmacist, even if they are adverse reactions not listed in this leaflet. See section 4.

Leaflet contents

  1. What Bilastina Alterpharma is and what it is used for
  2. What you need to know before taking Bilastina Alterpharma
  3. How to take Bilastina Alterpharma
  4. Possible side effects
  5. How to store Bilastina Alterpharma
  6. Contents of the pack and other information

1. What Bilastina Alterpharma is and what it is used for

Bilastina Alterpharm contains bilastine as the active substance, which is an antihistamine.

Bilastine is used to relieve the symptoms of allergic rhinoconjunctivitis (sneezing, nasal itching, nasal discharge, nasal congestion, and red, watery eyes) and urticaria (hives) when symptoms are mild, in adults and adolescents aged 12 years and older.

You should consult a doctor if your symptoms worsen or do not improve after 7 days.

2. What you need to know before taking Bilastina Alterpharma

Do not take Bilastina Alterpharma

If you are allergic to bilastine or to any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Consult your doctor or pharmacist before taking bilastine if you have moderate or severe renal impairment, low blood levels of potassium, magnesium, or calcium, if you have or have had heart rhythm problems or if your heart rate is very low, if you are taking medicines that may affect heart rhythm, or if you have or have had a specific abnormal heart rhythm pattern (known as QTc interval prolongation on the electrocardiogram), which may occur in certain types of heart disease and you are also taking other medicines (see “Other medicines and bilastine”).

If you experience symptoms such as difficulty breathing, abdominal pain, nausea, vomiting, diarrhea, dizziness, or fainting, seek urgent medical attention due to risk of anaphylaxis.

Children

Do not administer this medicine to children under 12 years of age.

Do not exceed the recommended dose. If symptoms persist, consult your doctor.

Other medicines and Bilastina Alterpharma

Inform your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines, including those obtained without a prescription.

In particular, please discuss with your doctor if you are taking any of the following medicines:

  • Ketoconazole (a medicine for fungal infections)
  • Erythromycin (an antibiotic)
  • Diltiazem (used to treat angina)
  • Cyclosporine (used to reduce the activity of your immune system, to prevent transplant rejection, or to reduce the activity of autoimmune diseases and allergic disorders such as psoriasis, atopic dermatitis, or rheumatoid arthritis)
  • Ritonavir (used to treat AIDS)
  • Rifampicin (an antibiotic).

Taking Bilastina Alterpharma with food, drinks, and alcohol

These tablets must not be taken with food or with grapefruit juice or other fruit juices, as this would reduce the effect of bilastine. To avoid this, you may:

  • take the tablet and wait one hour before eating or drinking fruit juice, or
  • if you have eaten food or drunk fruit juice, wait two hours before taking the tablet.

Bilastine, at the recommended dose (20 mg), does not increase drowsiness caused by alcohol.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before using this medicine.

There are no data or the data are limited on the use of bilastine in pregnant women, during breastfeeding, or on effects on fertility.

Consult your doctor or pharmacist before using any medicine.

Driving and using machines

Bilastine has been shown not to affect driving performance in adults. However, individual patient response to the medicine may vary. Therefore, assess how this medicine affects you before driving or operating machinery.

This medicine contains sodium

This medicine contains less than 23 mg of sodium (1 mmol) per tablet; that is, essentially “sodium-free”.

3. How to take Bilastina Alterpharma

Follow exactly the instructions for use provided in this leaflet or those given by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.

The recommended dose in adults, including elderly patients and adolescents aged 12 years and older, is 1 tablet (20 mg) daily.

  • The tablet is for oral use.
  • The tablet should be taken one hour before or two hours after eating food or drinking fruit juice (see section 2, “Taking Bilastina Alterpharma with food, drinks and alcohol”).
  • Swallow the tablet with a glass of water.

Consult a doctor if your condition worsens or if you do not improve after 7 days.

Use in children

For children aged 6 to 11 years with a minimum body weight of 20 kg, other more suitable pharmaceutical forms are available – bilastine 10 mg orodispersible tablets or bilastine 2.5 mg/ml oral solution. Consult your doctor or pharmacist.

Do not administer this medicine to children under 6 years of age with a body weight below 20 kg, as sufficient data are not available.

If you take more Bilastina Alterpharma than you should

If you, or anyone else, exceed the recommended dose of this medicine, inform your doctor immediately or go to the nearest hospital emergency department. Please remember to bring this medicine’s packaging or this leaflet with you.

In case of overdose or accidental ingestion, contact your doctor or pharmacist immediately, or call the Toxicology Information Service, telephone: 91 562 04 20 (indicating the medicine and the amount ingested).

If you forget to take Bilastina Alterpharma

Do not take a double dose to make up for a missed dose.

If you forget to take your dose, take it as soon as possible, and then return to your regular dosing schedule.

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible adverse effects

Like all medicines, this medicine can cause adverse effects, although not everyone will experience them.

If you experience allergic reactions, whose symptoms may include difficulty breathing, dizziness, collapse or loss of consciousness, swelling of the face, lips, tongue or throat and/or skin swelling and redness, stop taking this medicine immediately and contact your doctor without delay.

Other adverse effects that may occur in adults and adolescents are:

Common: may affect up to 1 in 10 people

  • headache
  • drowsiness

Uncommon: may affect up to 1 in 100 people

  • electrocardiogram abnormalities
  • blood tests showing changes in liver function
  • dizziness
  • stomach pain
  • fatigue
  • increased appetite
  • irregular heartbeat
  • weight gain
  • nausea (feeling sick)
  • anxiety
  • dry nose or nasal discomfort
  • abdominal pain
  • diarrhoea
  • gastritis (inflammation of the stomach lining)
  • vertigo (a sensation of dizziness or instability)
  • feeling weak
  • thirst
  • dyspnoea (difficulty breathing)
  • dry mouth
  • indigestion
  • itching
  • cold sores
  • fever
  • tinnitus (ringing in the ears)
  • difficulty sleeping
  • blood tests showing changes in kidney function
  • increased blood fats

Frequency not known: cannot be estimated from available data

  • palpitations (awareness of heartbeats)
  • tachycardia (rapid heartbeat)
  • vomiting

Adverse effects that may occur in children:

Common: may affect up to 1 in 10 people

  • rhinitis (nasal irritation)
  • allergic conjunctivitis (eye irritation)
  • headache
  • stomach pain (abdominal pain/upper abdominal pain)

Uncommon: may affect up to 1 in 100 people

  • eye irritation
  • dizziness
  • loss of consciousness
  • diarrhoea
  • nausea (feeling sick)
  • swelling of the lips
  • eczema
  • urticaria (hives)
  • fatigue

Reporting of adverse effects

If you experience any adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this leaflet. You may also report them directly via the Spanish Pharmacovigilance System for Human Medicines: https://www.notificaram.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. Storage of Bilastina Alterpharma

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date stated on the packaging after EXP. The expiry date is the last day of the month indicated.

This medicine does not require any special storage conditions.

Medicines must not be disposed of via wastewater or household waste. Dispose of empty containers and unused medicines at the Sigre Point in your pharmacy. If you have any doubts, ask your pharmacist how to properly dispose of containers and unused medicines. This will help protect the environment.

6. Contents of the pack and other information

Composition of Bilastina Alterpharma

The active substance is bilastine. Each tablet contains 20 mg of bilastine.

The other components are microcrystalline cellulose, sodium carboxymethylstarch type A (derived from potato), anhydrous colloidal silica, magnesium stearate.

Appearance of the medicine and contents of the pack

Round, biconvex tablets, white to almost white in colour.

The tablets are packed in blisters within packs containing 7, 14 and 20 tablets.

Marketing Authorisation Holder and Manufacturer

Laboratorios Alter, S.A.

C/ Mateo Inurria, 30

28036 Madrid

Spain

Date of the most recent review of this leaflet: February 2025

Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.